FdaApplication
NDA 203214
Identifiers
- fda_app_no: NDA203214
Properties
| Property | Value |
|---|---|
| applicant_name | PF PRISM CV |
| application_type | NDA |
| approval_date | 2012-11-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XELJANZ | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET;ORAL |
| XELJANZ | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET;ORAL |
2 products